首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3750973篇
  免费   333750篇
  国内免费   14319篇
耳鼻咽喉   52481篇
儿科学   120139篇
妇产科学   98124篇
基础医学   582871篇
口腔科学   103569篇
临床医学   342286篇
内科学   673555篇
皮肤病学   99279篇
神经病学   323473篇
特种医学   150842篇
外国民族医学   497篇
外科学   588440篇
综合类   114111篇
现状与发展   92篇
一般理论   2392篇
预防医学   309389篇
眼科学   87638篇
药学   260445篇
  17篇
中国医学   10158篇
肿瘤学   179244篇
  2021年   56149篇
  2020年   37472篇
  2019年   58753篇
  2018年   74577篇
  2017年   57273篇
  2016年   63413篇
  2015年   77254篇
  2014年   114226篇
  2013年   179271篇
  2012年   99935篇
  2011年   100390篇
  2010年   122213篇
  2009年   127836篇
  2008年   88133篇
  2007年   90736篇
  2006年   102446篇
  2005年   96756篇
  2004年   98963篇
  2003年   89155篇
  2002年   78907篇
  2001年   122229篇
  2000年   116176篇
  1999年   112802篇
  1998年   68479篇
  1997年   65765篇
  1996年   63453篇
  1995年   59004篇
  1994年   52851篇
  1993年   49242篇
  1992年   83323篇
  1991年   79904篇
  1990年   76342篇
  1989年   75028篇
  1988年   69803篇
  1987年   68469篇
  1986年   65255篇
  1985年   65073篇
  1984年   56734篇
  1983年   51399篇
  1982年   44860篇
  1981年   41986篇
  1980年   39578篇
  1979年   49039篇
  1978年   41012篇
  1977年   36846篇
  1976年   34137篇
  1975年   32893篇
  1974年   35612篇
  1973年   34256篇
  1972年   31762篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
63.
64.
65.
Major depressive disorder and other neuropsychiatric disorders are often managed with long-term use of antidepressant medication. Fluoxetine, an SSRI antidepressant, is widely used as a first-line treatment for neuropsychiatric disorders. However, fluoxetine has also been shown to increase the risk of metabolic diseases such as non-alcoholic fatty liver disease. Fluoxetine has been shown to increase hepatic lipid accumulation in vivo and in vitro. In addition, fluoxetine has been shown to alter the production of prostaglandins which have also been implicated in the development of non-alcoholic fatty liver disease. The goal of this study was to assess the effect of fluoxetine exposure on the prostaglandin biosynthetic pathway and lipid accumulation in a hepatic cell line (H4-II-E-C3 cells). Fluoxetine treatment increased mRNA expression of prostaglandin biosynthetic enzymes (Ptgs1, Ptgs2, and Ptgds), PPAR gamma (Pparg), and PPAR gamma downstream targets involved in fatty acid uptake (Cd36, Fatp2, and Fatp5) as well as production of 15-deoxy-Δ12,14PGJ2 a PPAR gamma ligand. The effects of fluoxetine to induce lipid accumulation were attenuated with a PTGS1 specific inhibitor (SC-560), whereas inhibition of PTGS2 had no effect. Moreover, SC-560 attenuated 15-deoxy-Δ12,14PGJ2 production and expression of PPAR gamma downstream target genes. Taken together these results suggest that fluoxetine-induced lipid abnormalities appear to be mediated via PTGS1 and its downstream product 15d-PGJ2 and suggest a novel therapeutic target to prevent some of the adverse effects of fluoxetine treatment.  相似文献   
66.
Cognitive Therapy and Research - Despite interest in psychological inflexibility as a marker of suicide risk, no measure of psychological inflexibility specific to SI exists. The present study...  相似文献   
67.
68.
69.
70.
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号